/Companies

SAGA Diagnostics

Research Triangle Park, US · Founded 2016 · 91 employees on LinkedIn · 5 known investors

Find your way into SAGA Diagnostics

Sign up to see every warm intro you have to SAGA Diagnostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the SAGA Diagnostics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages. The company serves oncology and treatment decision-making in the healthcare sector.

Founders & leadership

RBRoopom Banerjee
Roopom BanerjeeExecutive ChairmanRoopom Banerjee is Executive Chairman of SAGA Diagnostics, a molecular diagnostics company developing residual disease testing for early cancer detection. He brings expertise in corporate finance, M&A, and operations across pharmaceuticals, medical devices, and diagnostics.

Investors · 5

Also in the syndicate · 1

Segulah Medical Accelerationlead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does SAGA Diagnostics do?
SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages. The company serves oncology and treatment decision-making in the healthcare sector.
Who are SAGA Diagnostics's investors?
SAGA Diagnostics's investors include FSG, Hadean Ventures, LU Innovation, Sciety.
Where is SAGA Diagnostics headquartered?
SAGA Diagnostics is headquartered in Research Triangle Park, US.